chartexchange

CRBP
Corbus Pharmaceuticals Holdings, Inc.
stockNASDAQ

Market OpenNov 19, 2026 2:29:32 PM EST
2.48USD-9.654%(-0.27)405,133
Pre-marketNov 19, 2026 8:08:30 AM EST
2.76USD+0.546%(+0.01)
2.4700Bid2.4800Ask0.0100Spread
Loading…
Loading…
Healthcare
Biotechnology
CEO
Yuval Cohen
HQ
Norwood, MA, USA
Previous Close
$2.75
Beta
1.80
52-Week High
$12.88 2026-05-22
52-Week Low
$2.62 2026-11-18
SMA 50
$5.24
SMA 200
$8.28
Avg. Vol 10D
839,359
Avg. Vol 30D
1.07M
Avg. Vol 90D
870,306
Relative Vol
0.37
13.69M
0.9700%
231
Feb 14, 2023 · 1-for-30 (reverse)
CRBP Profile

corbus pharmaceuticals holdings, inc. (nasdaq: crbp) is a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases with clear unmet needs. the company's lead product candidate, resunab™, is a first-in-class, oral anti-inflammatory drug that acts to resolve inflammation through an endogenous pathway. resunab is scheduled to commence three phase 2 clinical trials in 2015 for the treatment of cystic fibrosis, diffuse systemic sclerosis ("scleroderma") and dermatomyositis, three diseases in which inflammation contributes to disease progression. resunab also has the potential to treat additional rare, inflammatory diseases.

CRBP Performance
PeriodPriceDateChangeBeta
1W3.412026-11-12-26.98%-2.284
1M4.462026-10-19-44.17%3.217
3M9.992026-08-19-75.08%2.746
6M9.152026-05-19-72.79%1.896
1Y11.822025-11-19-78.93%1.798
2Y16.562024-11-19-84.96%—
5Y27.972021-11-19-91.10%1.369
CRBP Stock Summary

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) stock price today is $2.49, and today's volume is 400,520. CRBP is down 9.290% today. The 30 day average volume is 1.07M. CRBP market cap is $51.31M with 20.61M shares outstanding.